These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4976979)

  • 1. [Trypanosoma cruzi infection in mice following their sensitization with Trypanosoma lewisi].
    García W; Mühlpfordt H
    Rev Inst Med Trop Sao Paulo; 1969; 11(1):13-8. PubMed ID: 4976979
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective cross-immunity between Trypanosoma cruzi and T. lewisi.
    Kloetzel J; Deane MP
    Rev Inst Med Trop Sao Paulo; 1971; 13(1):31-6. PubMed ID: 4997796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protection of mice with Trypanosoma lewisi antigen and its fractions against experimental Trypanosoma cruzi infection].
    Fernández de Lara WG
    Rev Inst Med Trop Sao Paulo; 1972; 14(5):301-5. PubMed ID: 4630386
    [No Abstract]   [Full Text] [Related]  

  • 5. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of an avirulent (cultivated) strain of Trypanosoma cruzi against experimental infection in mice.
    Menezes H
    Rev Inst Med Trop Sao Paulo; 1968; 10(1):1-4. PubMed ID: 4971608
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralizing antibodies in Trypanosoma cruzi infection.
    Sánchez DO; González Cappa SM
    Medicina (B Aires); 1983; 43(1):41-6. PubMed ID: 6410148
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of antigens of culture forms of Trypanosoma cruzi and Trypanosoma rangeli recognized by sera from patients with chronic Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1984 Oct; 70(5):822-4. PubMed ID: 6439848
    [No Abstract]   [Full Text] [Related]  

  • 10. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: effective dose, time, route, and number of vaccinations.
    Ritter DM; Rowland EC
    J Parasitol; 1984 Oct; 70(5):755-9. PubMed ID: 6439845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of adjuvants in the vaccination of mice with lyophilized "trypanosoma cruzi".
    Menezes H
    Hospital (Rio J); 1965 Dec; 68(6):1341-6. PubMed ID: 4955323
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of congenitally athymic mice against Trypanosoma cruzi infection by passive antibody transfer.
    Kierszenbaum F
    J Parasitol; 1980 Aug; 66(4):673-5. PubMed ID: 6775071
    [No Abstract]   [Full Text] [Related]  

  • 13. Trypanosoma cruzi antibodies in mice infected with different strains of T.cruzi.
    Peralta JM; Filardi L; Loures MA; Torres ST
    J Parasitol; 1980 Apr; 66(2):342-4. PubMed ID: 6771373
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of counterimmunoelectrophoresis in the study of immunogenic components of T. cruzi].
    Rubiolo ER; Vottero-Cima E; Rovai L
    Medicina (B Aires); 1980; 40 Suppl 1():127-31. PubMed ID: 6779076
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.
    Krettli AU; Brener Z
    J Immunol; 1982 May; 128(5):2009-12. PubMed ID: 6801127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance produced in mice and rats by inoculation with irradiated Trypanosoma rhodesiense.
    Duxbury RE; Sadun EH
    J Parasitol; 1969 Aug; 55(4):859-65. PubMed ID: 4980777
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple model for the interaction between T. cruzi and its antibodies during Chagas infection.
    Isasi SC; Sibona GJ; Condat CA
    J Theor Biol; 2001 Jan; 208(1):1-13. PubMed ID: 11162048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in complement fixing antibody in experimental Trypanosoma cruzi infection.
    Seah S; Marsden PD
    Trans R Soc Trop Med Hyg; 1969; 63(4):424-5. PubMed ID: 4980622
    [No Abstract]   [Full Text] [Related]  

  • 19. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
    Martin D; Tarleton R
    Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.